Episodes of a rare but severe multisystem inflammatory syndrome in children (MIS-C) associated with the novel coronavirus were reported in some regions across the globe.
A recent study published in Morbidity and Mortality Weekly Report shows a similar syndrome in 27 adults with the novel coronavirus.
About The Study
The study was carried out by the US Centers for Disease Control and Prevention (CDC). It involved identifying suspect cases of the syndrome among health reports and published case reports from particular areas.
Though the patients weren’t severely ill with COVID-19, they had cardiovascular, gastrointestinal, neurologic, and dermatologic signs and symptoms and specific biomarkers of inflammation and abnormal blood clotting consistent with the multisystem inflammatory syndrome in adults (MIS-A).
They tested positive for coronavirus on polymerase chain reaction (PCR) or antibody verifying, showing current or recent infection.
Similarly, regular signs and symptoms in children diagnosed with a similar symptom are cardiac dysfunctions, shock, high C-reactive protein (CRP), stomach pain, interleukin-6, and ferritin, all signs of inflammation. Also, D-dimer was present, a telltale sign of abnormal clotting.
Sixteen MIS-A patients described in reports and CDC data proved that all had traces of syndrome-related heart problems like unusual rhythms, high troponin concentration, or ventricular dysfunction.
Thirteen patients manifested gastrointestinal symptoms during hospital admission. Five of them had dermatologic abnormalities, more than half of them with mucositis, painful ulceration, and the digestive lining tract’s inflammation that usually happens after chemotherapy or radiation for cancer.
Ten of the sixteen patients manifested lung abnormalities on chest imaging, and twelve of them had a fever for over 24 hours.
As you can see, the syndrome is quite severe and shouldn’t be left untreated as it can lead to painful complications.